Interim Results

System C Healthcare plc 25 January 2006 System C Healthcare plc: Interim Results System C Healthcare plc ("the Company"), a leading independent provider of IT implementation solutions for the UK healthcare sector, announces its unaudited results for the six months ended 30 November 2005. Financial Summary â€¢ Turnover Â£8.6m (2004: Â£8.8m) â€¢ Profit before tax and exceptional items Â£0.6m (2004: Â£2.1m) â€¢ Profit before tax Â£0.4m (2004: Â£1.7m) â€¢ Basic earnings per share 0.79p (2004: 2.62p) â€¢ Operating cash outflow Â£0.3m (2004: Â£1.3m inflow) â€¢ Net cash Â£7.0m (2004: Â£3.8m net debt) â€¢ Interim dividend of 0.11 pence per share declared (see note 18) For further information please contact Jim Horsburgh, Chairman, or Ian Denley, Chief Executive Tel: 01622 691616 Brian Hudspith or Emma Burdett, The Maitland Consultancy Tel: 020 7379 5151 Half-Year Review Trading Results Six months to Six months to Year ended 31 30 November 2005 30 November 2004 May 2005 (unaudited) (unaudited) (audited) Â£000 Â£000 Â£000 ------------ ------------ ------------ Turnover 8,581 8,843 18,228 Total operating expenses before exceptional items (1) (8,240) (6,736) (14,735) ------------ ------------ ------------ Operating profit before exceptional items 341 2,107 3,493 Exceptional items (191) (360) (986) ------------ ------------ ------------ Operating profit 150 1,747 2,507 Net interest 250 (37) 25 ------------ ------------ ------------ Profit before tax 400 1,710 2,532 ------------ ------------ ------------ Note 1: Relates to cost of sales plus administrative expenses before exceptional items. Turnover was Â£8.6m in the six months ended 30 November 2005 (2004: Â£8.8m), with an operating profit before exceptional items of Â£0.3m (2004: Â£2.1m) which delivered a profit before tax of Â£0.4m (2004: Â£1.7m). Review of Activities As indicated in our December trading statement, delays to the National Programme for IT have seriously impacted turnover and profitability for the six months ended 30 November 2005. These delays have mostly affected the Services component of the Company's business with a decline in demand for time and materials work on NHS projects. We have responded rapidly to this change in the market, and have introduced a new range of fixed-price services which we are now starting to deliver into our major Local Service Provider ("LSP") customers. An example of this is the deployment of replacement patient administration systems at a number of trusts in the Midlands and the East of England, for which System C is taking complete responsibility and ownership. The services team have been associated with 20 major new trust-wide projects over the period. Outside the core implementation related activities with LSPs, we continue to win contracts directly from NHS Trusts, with 14 new contracts in the period. We have also recently won two deployment contracts with other third-party suppliers. The product capability of the Company has benefited from the continued investment during the period. Work has been undertaken to upgrade the MedWay Electronic Patient Record system to connect to the NHS Connecting for Health central Choose & Book system which allows general practitioners to book hospital appointments for their patients online. MedWay achieved its certification for Choose & Book compliance, and implementations of the new version are planned to begin in the second half of the year. We have also successfully launched new products in the HealthData Suite which provide data validation, reporting and management information systems configured specifically to support the healthcare sector. Seven new NHS hospital trust customers have been secured for such products in the six months to 30 November 2005, with renewable licence fee agreements for the provision of such solutions. In addition to the increased awareness of the Company's capabilities, and a broadening customer base, the financial position of the Company has been strengthened considerably by the flotation on AIM in June which provided Â£8.5 m of net cash for the business. The strengthening of the balance sheet to a position of Â£7.0m net cash at 30 November 2005 (Â£3.8m net debt at 30 November 2004) is particularly important for the Company's future growth and positioning. Earnings per share and Dividends Basic earnings per share for the six months ended 30 November 2005 of 0.79 pence per share (2004: 2.62 pence) is explained in note 9 below. Reflecting the Board's confidence in the Company's prospects in the medium term and beyond, an interim dividend of 0.11pence per ordinary share is declared in line with our policy stated at the time of the Company's flotation on AIM last June. This will be paid on 14 March to those shareholders on the register at the close of business on 17 February 2006 (see note 18). Prospects During the first six months of the current financial year we maintained capacity during a period of high opportunity. However, the slippage in the National Programme has had a significant impact on the outcome of the current financial year. Although prospects for the medium term remain good, the Company is restructuring to maintain profitability against slower market conditions at present. With trading conditions in the second half of the year likely to be similar to those in the six months ended 30 November 2005, we intend to reduce our operating cost base in the second half. We intend to ensure that the annualised operating cost base is reduced by between approximately Â£1.5m to Â£2.5m depending upon market conditions. This reduction will mainly impact the financial year ending 31 May 2007. However, the Company has made considerable progress in terms of its market positioning, and we remain confident that the medium term outlook for healthcare IT is positive. Accordingly, we intend to maintain our operational and development capacity with a core level of direct staff remaining focused on revenue generating and product development activities. In summary, the Company has a strong balance sheet and is well positioned to benefit from any upturn in the healthcare IT sector and generate significant profitability in the medium term and beyond. Ian Denley - Chief Executive Jim Horsburgh - Chairman 25 January 2006 Profit and loss account for the six months ended 30 November 2005 Six months Six months ended ended 30 November 30 November Year ended 2005 2004 31 May 2005 Note (unaudited) (unaudited) (audited) Â£ Â£ Â£ ---------- ----------- ---------- Turnover 3 8,580,971 8,842,818 18,228,185 Cost of sales 3 (4,134,987) (4,286,383) (8,757,318) ---------- ----------- ---------- Gross profit 3 4,445,984 4,556,435 9,470,867 ---------- ----------- ---------- Administration expenses - before 3 (4,104,984) (2,449,477) (5,978,204) exceptional items Administration expenses - exceptional 3,4 (190,632) (359,522) (986,004) items ---------- ----------- ---------- Administration expenses - total (4,295,616) (2,808,999) (6,964,208) ---------- ----------- ---------- Operating profit 3 150,368 1,747,436 2,506,659 Interest receivable and similar income 5 345,067 157,420 351,830 Interest payable and similar charges 6 (95,011) (194,953) (326,914) ---------- ----------- ---------- Profit on ordinary activities before taxation 400,424 1,709,903 2,531,575 Tax on profit on ordinary activities 7 267,472 (136,315) (421,882) ---------- ----------- ---------- Profit for the financial period 667,896 1,573,588 2,109,693 Dividends and appropriations 8 (12,796) (34,271) (66,742) ---------- ----------- ---------- Retained profit for the financial period 655,100 1,539,317 2,042,951 ---------- ----------- ---------- Earnings per share (as restated) Basic 9 0.79 2.62 3.48 Diluted 9 0.77 2.31 3.08 ---------- ----------- ---------- The results above relate entirely to continuing operations The Company has no recognised gains and losses other than the results above and therefore no separate statement of total recognised gains and losses has been presented. There is no difference between the profit on ordinary activities before taxation and the results for the periods stated above and their historical cost equivalents. Details of the restatement in respect of the earnings per share figures are given in note 2. Balance sheet as at 30 November 2005 Six months Six months ended ended 30 November 30 November Year ended 2005 2004 31 May 2005 Note (unaudited) (unaudited) (audited) Â£ Â£ Â£ ---------- ----------- ---------- Tangible fixed assets 1,563,697 1,962,656 2,017,883 ---------- ----------- ---------- Debtors 10 8,358,017 8,425,059 8,318,821 Cash at bank and in hand 9,450,289 332,261 1,223,242 ---------- ----------- ---------- Current assets 17,808,306 8,757,320 9,542,063 Creditors: amounts falling due within one year 11 (3,525,544) (4,137,584) (4,314,872) ---------- ----------- ---------- Net current assets 14,282,762 4,619,736 5,227,191 ---------- ----------- ---------- Total assets less current liabilities 15,846,459 6,582,392 7,245,074 Creditors: amounts falling due after more than one year 12 (1,024,511) (1,996,668) (1,520,488) Provisions for liabilities and charges 13 (97,683) (90,497) (233,895) ---------- ----------- ---------- (1,122,194) (2,087,165) (1,754,383) ---------- ----------- ---------- Net assets 14,724,265 4,495,227 5,490,691 ---------- ----------- ---------- Called up share capital 14 884,594 3,795,630 3,821,683 Share premium account 15 9,624,055 3,774,613 - Capital redemption reserve 15 3,127,023 134 134 Special reserve 15 - - 1,308,496 Own shares held in trust 15 (1,235,381) - - Profit and loss account 15 2,323,974 (3,075,150) 360,378 ---------- ----------- ---------- Total shareholders' funds 16 14,724,265 4,495,227 5,490,691 ---------- ----------- ---------- Represented by: Equity shareholders' funds 15 14,724,265 950,937 1,909,093 Non-equity shareholders' funds 15 - 3,544,290 3,581,598 ---------- ----------- ---------- Total 14,724,265 4,495,227 5,490,691 ---------- ----------- ---------- Cash flow statement for the six months ended 30 November 2005 Six months Six months ended ended 30 November 30 November Year ended 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ---------- ---------- ---------- Operating profit 150,368 1,747,436 2,506,659 Depreciation of tangible fixed assets 490,699 424,964 892,135 Loss on disposal of fixed assets - - 17,498 Exceptional charge on share options - 359,522 986,004 Movement in provisions (136,212) 49,700 54,536 Decrease in stocks - 7,902 7,902 Decrease/(increase) in debtors 207,306 (2,012,417) (2,177,636) (Decrease)/increase in creditors (1,047,234) 740,583 1,923,589 ---------- ---------- ---------- Net cash (outflow)/ inflow from operating activities (335,073) 1,317,690 4,210,687 Returns on investments and servicing of finance Interest received 355,552 157,420 341,345 Interest paid (95,011) (194,953) (326,914) Dividends paid to non-equity preference shareholders (123) - - ---------- ---------- ---------- Net cash inflow/(outflow)from returns on investments and servicing of finance 260,418 (37,533) 14,431 Taxation - 105,638 105,638 Capital expenditure and financial investment Purchase of tangible assets (42,252) (372,972) (890,728) ---------- ---------- ---------- Cash outflow from capital expenditure and financial investment (42,252) (372,972) (890,728) ---------- ---------- ---------- Net cash outflow/(inflow) before financing (116,907) 1,012,823 3,440,028 Financing Issue of equity share capital 11,059,720 - 138,362 Issue costs (1,354,461) - - Payments to acquire own shares held in trust (1,235,381) - - Redemption of non-equity preference shares (71,000) - - Net repayment of financing loans (457,049) (473,689) (912,502) ---------- ---------- ---------- Net cash inflow/(outflow) from financing 7,941,829 (473,689) (774,140) ---------- ---------- ---------- Increase in cash 7,824,922 539,134 2,665,888 ---------- ---------- ---------- Notes to interim report and accounts 1. Status of interim report and accounts The interim report and accounts are unaudited but have been reviewed by the auditors and their independent review report is set out on page 18. The interim report and accounts are not full accounts within the meaning of section 240 of the Companies Act 1985. The figures for the year ended 31 May 2005 have been extracted from the audited annual report and accounts that have been filed with the Registrar of Companies. The audit report on that annual report and accounts was unqualified and did not contain a statement under Section 237(2) or (3) of the Companies Act 1985. 2. Accounting policies The interim report and accounts have been prepared using the accounting policies to be applied in the annual report and accounts for the year ending 31 May 2006. These are consistent with those included in the annual report and accounts for the year ended 31 May 2005 with the exception of the effect, if any, on the adoption of FRS 21, FRS 22 and UITF 38. Adoption of FRS 21 "Events after the balance sheet date" The adoption of FRS 21 has not had any material impact on the Company. There is no prior period adjustment required for the six months ended 30 November 2004 and the year ended 31 May 2005 in respect of dividends as all the requisite conditions required by FRS 21 had been satisfied. Adoption of FRS 22 "Earnings per share" FRS 22 "Earnings per share" has been adopted, which prohibits the presentation of non-standard earnings per share measures on the face of the profit and loss account. Following the conversion of the Company's convertible participating preference shares (note 14), and in accordance with the requirements of FRS 22, the earnings per share figures for the year ended 31 May 2005 as previously reported of 5.15p per share and 4.30p per share respectively have been restated to include the number of additional ordinary shares arising on conversion in the calculation of the weighted average number of ordinary shares in issue during the period. Adoption of UITF 38 "Accounting for ESOP Trusts" The System C Healthcare plc Employee Benefit Trust has been accounting for in accordance with UITF 38 which requires the shares held by the trust to be deducted from shareholders' funds. Further details of the System C Healthcare plc Employee Benefit Trust are given in note 15. 3. Segmental reporting The Company's sole activity is the design, development and implementation of computer hardware and software. The directors consider it appropriate to analyse the results and financial position of the Company as given below: Six months ended 30 November 2005 (unaudited) Development and shared Products Services services Total Â£ Â£ Â£ Â£ -------- -------- -------- -------- Turnover 1,896,429 6,684,542 - 8.580,971 Cost of sales (1,434,141) (2,700,846) - (4,134,987) -------- -------- -------- -------- Gross profit/(loss) 462,288 3,983,696 - 4,445,984 Administration expenses - before exceptional items (155,617) (1,381,262) (2,568,105) (4,104,984) -------- -------- -------- -------- Administration expenses - exceptional items - - (190,632) (190,632) -------- -------- -------- -------- Operating profit/(loss) 306,671 2,602,434 (2,758,737) 150,368 Net interest 56,852 - 193,204 250,056 -------- -------- -------- -------- Profit/(loss) before tax 363,523 2,602,434 (2,565,533) 400,424 -------- -------- -------- -------- Net assets 3,120,584 2,656,883 8,946,798 14,724,265 -------- -------- -------- -------- Six months ended 30 November 2004 (unaudited) Development and shared Products Services services Total Â£ Â£ Â£ Â£ -------- -------- -------- -------- Turnover 1,110,055 7,732,763 - 8,842,818 Cost of sales (1,322,905) (2,963,478) - (4,286,383) -------- -------- -------- -------- Gross profit/(loss) (212,850) 4,769,285 - 4,556,435 Administration expenses - before exceptional items (129,075) (921,462) (1,398,940) (2,449,477) -------- -------- -------- -------- Administration expenses - exceptional items - - (359,522) (359,522) -------- -------- -------- -------- Operating profit/(loss) (341,925) 3,847,823 (1,758,462) 1,747,436 Net interest 8,282 (36,483) (9,332) (37,533) -------- -------- -------- -------- Profit/(loss) before tax (333,643) 3,811,340 (1,767,794) 1,709,903 -------- -------- -------- -------- Net assets 1,877,729 2,166,269 451,229 4,495,227 -------- -------- -------- -------- Year ended 31 May 2005 (unaudited) Development and shared Products Services services Total Â£ Â£ Â£ Â£ -------- -------- -------- -------- Turnover 2,966,764 15,261,421 - 18,228,185 Cost of sales (2,330,372) (6,426,946) - (8,757,318) -------- -------- -------- -------- Gross profit/(loss) 636,392 8,834,475 - 9,470,867 Administration expenses - before exceptional items (272,981) (1,918,823) (3,786,400) (5,978,204) Administration expenses - exceptional items - - (986,004) (986,004) -------- -------- -------- -------- Operating profit/(loss) 363,411 6,915,652 (4,772,404) 2,506,659 Net interest 72,316 (62,666) 15,266 24,916 -------- -------- -------- -------- Profit/(loss)before tax 435,727 6,852,986 (4,757,138) 2,531,575 -------- -------- -------- -------- Net assets 2,044,603 2,504,230 941,858 5,490,691 -------- -------- -------- -------- The Products segment relates to business where the Company contracts directly with local NHS trusts and other clinical organisations. The Services segment relates to the business where the Company is subcontracted to perform work on behalf of other organisations where the end customer is also either the NHS or other clinical organisations. Development and shared services relates to the Company's central research and development activities and support services provided to the Products and Service segments. There is no difference between the geographical origin and destination of turnover, all of which arises in the United Kingdom. 4. Exceptional items Six months Six months ended ended 30 November 30 November Year ended 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ---------- ----------- UITF 17 charge - 318,725 806,645 UITF 25 charge - 40,797 179,359 Flotation costs 190,632 - - ----------- ---------- ----------- Total 190,632 359,522 986,004 ----------- ---------- ----------- UITF 17 and UITF 25 charges The charges above arise on the re-pricing of certain share options on 10 November 2004, together with the issue of additional share options during the year ended 31 May 2005. Flotation costs Such costs comprise amounts incurred in connection the Company's admission to AIM which have not been set off against the share premium account. 5. Interest receivable and similar income Six months Six months ended ended 30 November 30 November Year ended 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ---------- ----------- Bank interest receivable 195,154 1,379 20,458 Other interest receivable 149,913 156,041 331,372 ----------- ---------- ----------- 345,067 157,420 351,830 ----------- ---------- ----------- 6. Interest payable and similar charges Six months Six months ended ended 30 November 30 November Year ended 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ---------- ----------- Interest payable on bank loans and overdrafts 1,950 47,194 67,858 Interest on financing loans 93,061 147,759 259,056 ----------- ---------- ----------- 95,011 194,953 326,914 ----------- ---------- ----------- 7. Tax on profit on ordinary activities (a) Analysis of tax (credit)/charge in the period Six months Six months ended ended 30 November 30 November Year ended 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ---------- ----------- Analysis of charge in the period Current tax United Kingdom corporation tax at 19% on profit for the period - 262 3,887 ----------- ---------- ----------- Total current tax charge (note 7b) - 262 3,887 Deferred tax Origination and reversal of timing differences (267,472) 136,053 417,995 ----------- ---------- ----------- Total deferred tax (credit)/charge (267,472) 136,053 417,995 ----------- ---------- ----------- Tax on profit on ordinary activities (267,472) 136,315 421,882 ----------- ---------- ----------- (b) Factors affecting the tax charge in the period The tax for the period differs from the standard rate of corporation tax in the UK (30% for six months ended 30 November 2004 and the year ended 31 May 2004 and 19% for the six months ended 30 November 2005). The differences are explained below: Six months Six months ended ended 30 November 30 November Year ended 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ---------- ----------- Profit on ordinary activities before tax 400,424 1,709,903 2,531,575 Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 30% 120,127 512,971 759,473 ----------- ---------- ----------- Effects of: Expenses not deductible for tax purposes 7,673 11,798 35,797 Differences between capital allowances and depreciation 23,390 29,285 51,543 Unutilised losses/(losses utilised) 476,746 (633,229) (1,084,135) Other timing differences (232,664) 96,904 243,280 Other permanent differences (395,272) - - Net difference between standard rate of tax and small company rate - (17,467) (2,071) ----------- ---------- ----------- Total current tax charge (note 7a) - 262 3,887 ----------- ---------- ----------- 8. Dividends and appropriations Six months Six months ended ended 30 November 30 November Year ended 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ---------- ----------- Dividend appropriations on Â£1 preference shares - 4 7 Dividends/dividend appropriations on Â£1 convertible participating preference shares 12,796 34,267 66,735 ----------- ---------- ----------- 12,796 34,271 66,742 ----------- ---------- ----------- Dividends on the Company's convertible participating preference shares were calculated on a basis to give a constant rate of charge on the nominal value of such shares until their conversion immediately prior to the admission of the Company's ordinary shares to AIM as described in note 14. Please see note 18 in respect of the declaration of dividends after 30 November 2005. 9. Earnings per share Six months ended Six months ended (as restated) 30 November 30 November Year ended 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ---------- ----------- Retained profit for the financial period 655,100 1,539,317 2,042,951 Adjustment (See note a) 12,796 34,267 66,735 ----------- ---------- ----------- Retained profit for the period adjusted for appropriations of dividends on non-equity shares 667,896 1,573,584 2,109,686 Number Number Number ----------- ---------- ----------- Weighted average number of ordinary shares used for calculating basic earning per share (see note b) 84,509,607 59,774,032 60,568,411 Potentially dilutive shares arising from share options (see note c) 2,089,602 7,768,908 7,890,523 ----------- ---------- ----------- Used for calculating diluted earning per share 86,599,209 67,542,940 68,458,934 Pence Pence Pence ----------- ---------- ----------- Basic earnings per share 0.79 2.62 3.48 Diluted earnings per share 0.77 2.31 3.08 ----------- ---------- ----------- Details of the restatement in respect of the earnings per share figures are given in note 2. Note a: Adjustment relates to non-equity dividend/dividend appropriations on the Company's Â£1 convertible participating preference shares which were converted into ordinary shares immediately prior to the admission of its ordinary shares to AIM as described in note 14. Note b: Includes number of shares arsing from conversion of the Company's Â£1 convertible participating preference shares which were converted into ordinary shares immediately prior to the admission of its ordinary shares to AIM as described in note 14. Note c: For the six months ended 30 November 2004 and the year ended 31 May 2005, the share price used to determine the number of potentially dilutive shares arising from share options was 54p per share - i.e. the price at the time of admission to AIM. The average share price for the six months ended 30 November 2005 has been used to calculate the number of potentially dilutive shares arising from share options in the period ended 30 November 2005. 10. Debtors 30 November 30 November 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ---------- ----------- ----------- Amounts falling due within one year: Trade debtors 1,987,458 3,898,282 3,399,174 Other debtors 70,748 4,055 28,705 Prepayments and accrued income 5,220,334 3,428,775 4,078,937 Deferred tax asset (see below) 1,079,477 1,093,947 812,005 ---------- ----------- ----------- 8,358,017 8,425,059 8,318,821 ---------- ----------- ----------- Prepayments and accrued income as at 30 November 2005, 30 November 2004 and 31 May 2005 include amounts of Â£4,804,391, Â£3,089,484 and Â£3,592,329 in respect of revenue that has been recognised by the Company but which had not been invoiced to the customer as at the period end. The balance as at 30 November 2005 reflects an additional Â£232,000 recognised following a review by management with the corresponding amount included in turnover for the six month period then ended. Of the total amount of accrued income as at 30 November 2005, 30 November 2004 and 31 May 2005, Â£1,904,788, Â£1,224,009, and Â£1,923,372 respectively were due after more than one year at the end of each of the financial periods. Deferred tax asset 30 November 30 November 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ---------- ----------- ----------- Balance at start of period 812,005 1,230,00 1,230,000 Credited/(charged) to the profit and loss account (note 7a) 267,472 (136,05 (417,995) ---------- ----------- ----------- Balance at end of period 1,079,477 1,093,947 812,005 ---------- ----------- ----------- 30 November 30 November 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ---------- ----------- ----------- Deferred tax recognised comprises: Accelerated capital allowances (86,741) (132,388) (110,131) Unutilised tax losses 1,153,802 1,127,631 677,056 Short term timing differences - 95,618 241,994 Other 12,416 3,086 3,086 ---------- ----------- ----------- Deferred tax asset (net) 1,079,477 1,093,947 812,005 ---------- ----------- ----------- The Company had no unrecognised deferred tax as at the end of each of the financial periods above 11. Creditors - Amounts falling due within one year 30 November 30 November 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ---------- ----------- ----------- Bank loans and overdrafts 414,887 1,248,535 12,762 Financing loans 972,091 895,796 933,163 Trade creditors 266,672 347,935 736,030 Other taxation and social security 759,556 1,015,149 1,311,804 Proposed dividends - - 166,923 Corporation tax 4,796 1,171 4,796 Accruals and deferred income 1,107,542 628,998 1,149,394 ---------- ----------- ----------- 3,525,544 4,137,584 4,314,872 ---------- ----------- ----------- 12. Creditors - Amounts falling due after more than one year 30 November 30 November 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ---------- ----------- ----------- Financing loans 1,024,511 1,996,668 1,520,488 ---------- ----------- ----------- 13. Provisions for liabilities and charges 30 November 30 November 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ---------- ----------- ----------- Dilapidations provision 65,648 49,700 54,536 UITF 25 provision 32,035 40,797 179,359 ---------- ----------- ----------- 97,683 90,497 233,895 ---------- ----------- ----------- 14. Called up share capital Authorised 30 November 2005 30 November 2004 31 May 2005 (unaudited) (unaudited) (audited) Number Â£ Number Â£ Number Â£ -------- -------- -------- -------- -------- -------- 1p ordinary shares 405,000,000 4,050,000 65,000,000 650,000 65,000,000 650,000 Â£1 convertible participating preference shares - - 3,400,000 3,400,000 3,400,000 3,400,000 Â£1 Preference shares - - 71,000 71,000 71,000 71,000 -------- -------- -------- At end of period 4,050,000 4,121,000 4,121,000 -------- -------- -------- Allotted, called up and fully paid 30 November 2005 30 November 2004 31 May 2005 (unaudited) (unaudited) (audited) Number Â£ Number Â£ Number Â£ -------- -------- -------- -------- -------- -------- 1p ordinary shares At beginning of period 38,863,080 388,631 38,863,080 388,631 38,863,080 388,631 Allotments in period 49,596,279 495,963 - - 2,605,253 26,053 -------- -------- -------- -------- -------- -------- At end of period 88,459,359 884,594 38,683,080 388,631 41,468,333 414,684 -------- -------- -------- -------- -------- -------- Â£1 convertible participating preference shares At beginning of period 3,335,999 3,335,999 3,335,999 3,335,999 3,335,999 3,335,999 Conversion in the period (3,335,999) (3,335,999) - - - - -------- -------- -------- -------- -------- -------- At end of period - - 3,335,999 3,335,999 3,335,999 3,335,999 -------- -------- -------- -------- -------- -------- Â£1 Preference shares At beginning of period 71,000 71,000 71,000 71,000 71,000 71,000 Redemption in the period (71,000) (71,000) - - - - -------- -------- -------- -------- -------- -------- At end of period - - 71,000 71,000 71,000 71,000 -------- -------- -------- -------- -------- -------- Total share capital 884,594 3,795,630 3,821,683 -------- -------- -------- Changes to share capital prior to admission to AIM Immediately prior to the first admission of the Company's ordinary shares to AIM on 28 June 2005 each convertible participating preference share converted into 6.27 1p ordinary shares and 93.73 1p non-voting deferred shares. The cumulative unpaid dividend of Â£179,596 on the Company's convertible participating preference shares was also settled through this conversion mechanism and the corresponding entry has been credited to the share premium account. Immediately following the conversion the Company repurchased the non-voting deferred shares for nil consideration, cancelled them and re-designated the unissued non-voting deferred shares as 1p ordinary shares. The Company's redeemable preference shares were redeemed at par, plus the cumulative unpaid dividend, three business days after the admission of the Company's ordinary shares to AIM. Placing of shares and admission to AIM The first tranche of the Company's 1p ordinary shares were admitted to trading on AIM on 28 June 2005 following the placing of 7.2m such shares at a price of 54p per share. A second admission of 11.1m ordinary shares of 1p each occurred on 29 June 2005 also at a placing price of 54p per share. 15. Share premium account and reserves Share Capital Own shares premium redemption Special held Profit and account reserve reserve in trust loss account Â£ Â£ Â£ Â£ Â£ --------- --------- --------- --------- --------- As at 1 June 2004 3,774,613 134 - - (4,967,463) Retained profit for the period - - - - 1,539,317 Credit on appropriation of non-equity dividends - - - - 34,271 UITF17 charge on repricing/ grant of share options - - - - 318,725 --------- --------- --------- --------- --------- As at 30 November 2004 (unaudited) 3,774,613 134 - - (3,075,150) --------- --------- --------- --------- --------- Retained profit for the period - - - - 503,634 Credit on appropriation of non-equity dividends - - - - 32,471 UITF17 charge on grant of share options - 487,920 Premium on 1p ordinary shares issued 112,309 - - - - Transfer on capital reduction (see below) (3,886,922) - 864,522 - 3,022,400 Additional transfer on capital reduction (see below) - - 443,974 - (443,974) Accrual for non-equity dividends previously appropriated - - - - (166,923) --------- --------- --------- --------- --------- As at 31 May 2005 (audited) - 134 1,308,496 - 360,378 --------- --------- --------- --------- --------- Retained profit for the period - - - - 655,100 Credit arising on conversion of the Company's Â£1 convertible participating preference shares - 3,126,889 - - - Premium arising on settlement of accrued dividend (see note 14) 179,596 - - - - Premium on 1p ordinary shares issued 10,798,920 - - - - Issue costs (1,354,461) - - - - Release of special reserve (see below) - - (1,308,496) - 1,308,496 Employee benefits trust - - - 1,235,381 - --------- --------- --------- --------- --------- As at 30 November 2005 (unaudited) 9,624,055 3,127,033 - 1,235,381 2,323,974 --------- --------- --------- --------- --------- Capital reduction and transfer of special reserve An amount of Â£3,886,922 was standing to the credit of the Company's share premium account as at 31 January 2005 representing the aggregate of premiums at which shares of the Company have been issued. This amount could not be distributed by way of dividend but, with the approval, by special resolution, of the Company's shareholders in a general meeting and an order of confirmation of the High Court, it would be available to eliminate the deficit on the Company's profit and loss reserve, and hence enable the Company to re-register as a public company in advance of its admission to AIM. Accordingly, on 4 April 2005 the directors made an application to the Court to reduce the amount standing to the credit of the share premium account of Â£3,886,922 to Â£nil, which would result in the elimination of the deficit by the transfer of Â£3,022,400 to the profit and loss account and Â£864,522 to a special non-distributable reserve, in accordance with the instructions of the Court. In order to obtain the requisite confirmation from the Court for the reduction of the share premium account, the Company furnished the Court with the required undertakings to provide assurance in respect of the protection of the interests of the Company's creditors, which included the transfer of such profits earned by the company between 1 February 2005 and the effective date of the capital reduction to the afore-mentioned special reserve. Profits earned by the Company during this period amount to Â£443,974. The Court order specified that the Company would be able to reduce the amount credited to the special reserve equivalent to any increase in its paid up share capital or its share premium account arising from new consideration. Accordingly, the Company transferred Â£1,308,496 from the special reserve to the profit and loss reserve following the placing and admission of its ordinary shares to AIM. Own shares held in trust The System C Healthcare plc Employee Benefit Trust (the "Trust") holds 2,287,741 ordinary shares of 1p each with a cost of Â£1,235,381 and a market value as at 30 November 2005 of Â£1,092,396. The Trust acquired these shares at 54p each on the placing and admission of the Company's ordinary shares to AIM. The Trust used the funds loaned to it by System C Healthcare plc to meet the obligations under the various share option schemes that the Company operates. Share options are granted to the employees at the discretion of the Company and shares are awarded to employees by the Trust in accordance with the wishes of System C Healthcare plc. The loan provided to the Trust will be repaid from the proceeds payable by employees to exercise share options that have been granted to them. 16. Reconciliation of movements in shareholders' funds Six months ended Six months ended Year ended 30 November 2005 30 November 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ----------- ---------- Profit for the financial period 667,896 1,573,588 2,109,693 Dividends and appropriations (12,796) (34,271) (66,742) ----------- ----------- ---------- Retained profit for the financial period 655,100 1,539,317 2,042,951 Credit arising on appropriation in respect of non-equity shares - 34,271 66,742 Accrual for appropriated non-equity dividends - - (166,923) UITF 17 charge on grant of share options - 318,725 806,645 Proceeds from equity shares subscribed at par 260,800 - 26,053 Premium on new share capital subscribed (net of issue costs) 9,624,055 - 112,309 Own shares held in trust (1,235,381) - - Redemption of preference shares (71,000) - - ----------- ----------- ---------- Net increase in shareholders' funds 9,233,574 1,892,313 2,887,777 Opening shareholders' funds 5,490,691 2,602,914 2,602,914 ----------- ----------- ---------- Closing shareholders' funds 14,724,265 4,495,227 5,490,691 ----------- ----------- ---------- Analysis of shareholders' funds 30 November 30 November 31 May 2005 2005 2004 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ----------- ---------- Equity shareholders' funds 14,724,265 950,937 1,909,093 ----------- ----------- ---------- - Â£1 preference shares - 71,000 71,000 ----------- ----------- ---------- - Cumulative appropriations in respect of Â£1 preference shares - 120 123 ----------- ----------- ---------- 71,120 71,123 - Â£1 convertible participating preference shares - 3,335,999 3,335,999 ----------- ----------- ---------- - Cumulative appropriations in respect of Â£1 preference shares - 137,171 174,476 ----------- ----------- ---------- - 3,473,170 3,510,475 ----------- ----------- ---------- Non-equity shareholders' funds - 3,544,290 3,581,598 ----------- ----------- ---------- Total shareholders' funds 14,724,265 4,495,227 5,490,691 ----------- ----------- ---------- 17. Analysis of net funds/(debt) 30 November 30 November 2005 2004 31 May 2005 (unaudited) (unaudited) (audited) Â£ Â£ Â£ ----------- ----------- ---------- Cash at bank and in hand 9,450,289 332,261 1,223,242 Bank overdraft (414,887) (1,248,535) (12,762) ----------- ----------- ---------- Net cash/(overdraft) 9,035,402 (916,274) 1,210,480 Financing loans due within one year (972,091) (895,796) (933,163) Financing loans due in more than one year (1,024,511) (1,996,668) (1,520,488) ----------- ----------- ---------- Net funds/(debt) 7,038,800 (3,808,738) (1,243,171) ----------- ----------- ---------- 18. Post balance sheet events On 17 January 2006, the directors declared an interim dividend for the period ended 30 November 2005 of 0.11p per ordinary share. This interim dividend has not been reflected in the profit and loss account to 30 November 2005 in accordance with the requirements of FRS 21 as the requisite approvals had not been obtained at that date. The directors expect that the dividend will be paid on 14 March 2006. Independent review report to System C Healthcare plc Introduction We have been instructed by the company to review the financial information for the six months ended 30 November 2005 which comprises the summarised profit and loss account, summarised balance sheet information as at 30 November 2005, summarised cash flow statement and the related notes. We have read the other information contained in the interim report and considered whether it contains any apparent misstatements or material inconsistencies with the financial information. Directors' responsibilities The interim report, including the financial information contained therein, is the responsibility of, and has been approved by the directors. The directors are responsible for preparing the interim report in accordance with the AIM rules. The accounting policies are consistent with those that the directors intend to use in the preparation of the next annual financial statements. The maintenance and integrity of the System C Healthcare plc web site is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the interim report since it was initially presented on the web site. Legislation in the United Kingdom governing the preparation and dissemination of financial information may differ from legislation in other jurisdictions. Review work performed We conducted our review in accordance with guidance contained in Bulletin 1999/4 issued by the Auditing Practices Board for use in the United Kingdom. A review consists principally of making enquiries of management and applying analytical procedures to the financial information and underlying financial data and, based thereon, assessing whether the disclosed accounting policies have been applied. A review excludes audit procedures such as tests of controls and verification of assets, liabilities and transactions. It is substantially less in scope than an audit and therefore provides a lower level of assurance. Accordingly we do not express an audit opinion on the financial information. This report, including the conclusion, has been prepared for and only for the company for the purpose of compliance with the AIM rules and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing. Review conclusion On the basis of our review we are not aware of any material modifications that should be made to the financial information as presented for the six months ended 30 November 2005. PricewaterhouseCoopers LLP Chartered Accountants Gatwick 25 January 2006 This information is provided by RNS The company news service from the London Stock Exchange

Companies

Sysgroup (SYS)

Full Archive

UK 100

Latest directors dealings

All directors dealings today